G47Δ treatment of a syngeneic bilateral hepatoma model inhibited both injected and non-injected tumors, increased tumor-specific IFNγ splenocytes in vitro, and significantly increased CD8+ but not CD4+ T cells [55]. The gene discussed is CD8A; the disease is neoplasm.